Note: This is an archived Handbook entry from 2010.
|Dates & Locations:|| |
This subject has the following teaching availabilities in 2010:Semester 2, Parkville - Taught on campus.
Timetable can be viewed here. For information about these dates, click here.
|Time Commitment:||Contact Hours: 3 x one hour lectures per week (total contact hours: 36) |
Total Time Commitment: 120 hours
|Prerequisites:|| BSc students: |
Study Period Commencement:
Study Period Commencement:
|Recommended Background Knowledge:||None|
|Non Allowed Subjects:|| This subject cannot be taken if credit has been previously obtained for 534-302 Neuropharmacology. |
|Core Participation Requirements:||It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs. |
This subject requires all students to actively and safely participate in laboratory activities. Students who feel their disability may impact upon their participation are encouraged to discuss this with the subject coordinator and the Disability Liaison Unit:
CoordinatorAssoc Prof James Ziogas, Dr Peter Crack
Dr Peter Crack
Assoc Prof James Ziogasjamesz@unimelb.edu.au
Ms Hong Nguyen
The workings of the brain present one of the last true unknowns in modern medicine and yet it is the target for a multitude of interesting and important drugs. This subject will address the use of drugs in modulating the processes of neurochemical transmission and neuronal survival in the context of the management of mood and emotional disorders, addictive behaviours, neuro-degenerative diseases, pain and epilepsy. This subject will also discuss strategies for the development of future therapeutics and students will gain an appreciation of how a detailed understanding of pathological processes is important for the rational development of new therapeutics.
On successful completion of this unit, students will have developed a solid understanding of the pharmacology of central nervous system diseases and the knowledge of the actions of important drugs used clinically and in research into central nervous system disorders
Students will also gain an appreciation of how a detailed understanding of pathological processes is important for the rational development of new therapeutics.
|Prescribed Texts:||Nestler, Hymen & Malenka, |
Molecular Neuropharmacology McGraw Hill.
|Breadth Options:|| |
This subject potentially can be taken as a breadth subject component for the following courses:
You should visit learn more about breadth subjects and read the breadth requirements for your degree, and should discuss your choice with your student adviser, before deciding on your subjects.
|Fees Information:||Subject EFTSL, Level, Discipline & Census Date|
|Generic Skills:||By the end of this unit students will: |
This subject is available to students enrolled in the BSc, Biomedicine degree.
Bachelor of Science |
Graduate Diploma in Biotechnology
Biomedical Biotechnology |
Download PDF version.